Edgewise Therapeutics Inc (NASDAQ: EWTX) on Tuesday, plunged -13.06% from the previous trading day, before settling in for the closing price of $16.54. Within the past 52 weeks, EWTX’s price has moved between $10.60 and $38.12.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of -25.73%. With a float of $73.99 million, this company’s outstanding shares have now reached $94.84 million.
The firm has a total of 110 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Edgewise Therapeutics Inc (EWTX) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Edgewise Therapeutics Inc is 29.63%, while institutional ownership is 71.36%. The most recent insider transaction that took place on Apr 03 ’25, was worth 10,000,000. In this transaction Director of this company bought 496,771 shares at a rate of $20.13, taking the stock ownership to the 14,809,075 shares. Before that another transaction happened on Apr 03 ’25, when Company’s Director bought 496,771 for $20.13, making the entire transaction worth $10,000,000. This insider now owns 14,809,075 shares in total.
Edgewise Therapeutics Inc (EWTX) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -25.73% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -11.65% during the next five years compared to -49.00% drop over the previous five years of trading.
Edgewise Therapeutics Inc (NASDAQ: EWTX) Trading Performance Indicators
Edgewise Therapeutics Inc (EWTX) is currently performing well based on its current performance indicators. A quick ratio of 19.93 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.45, a number that is poised to hit -0.43 in the next quarter and is forecasted to reach -2.02 in one year’s time.
Technical Analysis of Edgewise Therapeutics Inc (EWTX)
Analysing the last 5-days average volume posted by the [Edgewise Therapeutics Inc, EWTX], we can find that recorded value of 1.17 million was lower than the volume posted last year of 1.57 million. As of the previous 9 days, the stock’s Stochastic %D was 58.91%. Additionally, its Average True Range was 1.42.
During the past 100 days, Edgewise Therapeutics Inc’s (EWTX) raw stochastic average was set at 15.18%, which indicates a significant decrease from 39.17% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 83.87% in the past 14 days, which was lower than the 87.84% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $19.69, while its 200-day Moving Average is $24.84. Now, the first resistance to watch is $15.91. This is followed by the second major resistance level at $17.45. The third major resistance level sits at $18.36. If the price goes on to break the first support level at $13.46, it is likely to go to the next support level at $12.55. Should the price break the second support level, the third support level stands at $11.01.
Edgewise Therapeutics Inc (NASDAQ: EWTX) Key Stats
Market capitalization of the company is 1.51 billion based on 104,774K outstanding shares. Right now, sales total 0 K and income totals -133,810 K. The company made 0 K in profit during its latest quarter, and -39,660 K in sales during its previous quarter.
